Douglas D Lenners, PT/ATC Physical Therapist - Sports Medicare: Not Enrolled in Medicare Practice Location: 801 Riverside, Suite 250, St. Joseph, MO 64505 Phone: 816-271-6636 Fax: 816-271-6645 |
Mrs. Kimberly Marie Alexander-goehring, R.P.T Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3002 N 18th St, St. Joseph, MO 64505 Phone: 816-387-8847 Fax: 816-387-8847 |
Mrs. Kathleen Marie Monach, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1343 Village Drive, St. Joseph, MO 64506 Phone: 816-232-2878 Fax: 816-232-5056 |
News Archive
Rapid increase in output from second-generation DNA sequencers has enabled new levels of productivity and new experiments. This, along with funding from the stimulus bill, has caused rapid adoption of these machines, according to healthcare market research firm Kalorama Information, helping to fuel sales of DNA sequencers to $480 million in 2008. In its report "DNA Sequencing Equipment and Services Markets, 2nd Edition," Kalorama says more changes are on the way and will drives sales growth of 19% annually through 2013.
An international team of scientists has announced a new advance in the fight against Alzheimer's disease by identifying a new drug target for not only improving symptoms of brain degeneration – but also to extend the life-span of the terminally ill mice.
A Michigan State University researcher is working to uncover how a protein known as parkin may help nerve cells fight off damage from Parkinson's disease, a strategy that could lead to new therapies for the degenerative ailment.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that in the treatment of dyslipidemia, surveyed cardiologists and primary care physicians (PCPs) now perceive AstraZeneca's Crestor's ability to reduce mortality comparable to Pfizer's Lipitor. This finding has changed from Decision Resources' 2009 analysis in which surveyed cardiologists viewed Lipitor as significantly better on this end point.
Grubb & Ellis Healthcare REIT II, Inc. today announced that it has entered into a $25 million secured revolving credit facility with Bank of America, National Association. The credit facility may be utilized to fund property acquisitions and for other general corporate purposes.
› Verified 8 days ago